Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide + Insulin Glargine in Type 2 Diabetes
NCT00976391Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Primary completion
- Oct 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 14
01
Overview
A Phase 3 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Sep 2009; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00976391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976391.